Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study

Colaboración

Año: 2022

Rugo, HS; O'Shaughnessy, J; Boyle, F; Toi, M; Broom, R; Blancas, I; Gumus, M; Yamashita, T; Im, YH; Rastogi, P; Zagouri, F; Song, C; Campone, M; San Antonio, B; Shahir, A; Hulstijn, M; Brown, J; Zimmermann, A; Wei, R; Johnston, SRD; Reinisch, M; Tolaney, SM

Título: ANNALS OF ONCOLOGY

• D1